Biocept, Inc.
(NASDAQ : BIOC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.19%197.231.2%$609.33m
GILDGilead Sciences, Inc.
-0.09%67.950.9%$502.77m
CELGCelgene Corporation
-3.03%67.301.2%$478.41m
BIIBBiogen Inc.
0.50%320.811.3%$469.94m
ILMNIllumina, Inc.
0.09%301.863.5%$382.05m
REGNRegeneron Pharmaceuticals, Inc.
0.30%340.022.6%$299.58m
VRTXVertex Pharmaceuticals Incorporated
-0.47%160.311.9%$259.31m
ALXNAlexion Pharmaceuticals, Inc.
1.95%117.302.0%$202.95m
AAgilent Technologies, Inc.
7.68%67.421.5%$200.27m
SRPTSarepta Therapeutics, Inc.
1.78%118.4415.4%$149.39m
LGNDLigand Pharmaceuticals Incorporated
1.87%151.3223.3%$142.18m
EXASExact Sciences Corporation
-3.48%64.9425.3%$132.25m
TSROTESARO, Inc.
16.11%42.7614.4%$127.00m
NKTRNektar Therapeutics
0.66%38.265.6%$123.05m
INCYIncyte Corporation
-0.83%63.722.5%$114.78m

Company Profile

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.